Senior insider sale
Chief Commercial Officer at SOLENO THERAPEUTICS INC — senior position signals high conviction
$2.40M
48K shares
What this filing means
MANNING MEREDITH plans to sell 48K shares of SOLENO THERAPEUTICS INC valued at approximately $2.40M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/27/2025ACC: 0001415889-25-009080
Officer· Chief Commercial Officer
Since Apr 2024
48K
Shares to sell
$2.40M
Approx. market value
48K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock option exercises
Cash
3/27/2025
37KVesting of Restricted Stock Units - See Remarks
Equity Compensation
3/26/2025
11KTotal acquired48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/27/2025 | Stock option exercises Cash | 37K | — |
3/26/2025 | Vesting of Restricted Stock Units - See Remarks Equity Compensation | 11K | — |
| Total | 48K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
48K
Market value
$2.40M
3/27/2025
Total
Units
48K
Value
$2.40M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/27/2025 | 48K | $2.40M | NASDAQ | Planned |
| Total | 48K | $2.40M | ||